These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 28474260

  • 1. The role of hepatic enzymes in Crohn's disease.
    Ribaldone DG, Astegiano M, Pellicano R.
    Int J Colorectal Dis; 2017 Sep; 32(9):1363-1364. PubMed ID: 28474260
    [No Abstract] [Full Text] [Related]

  • 2. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]

  • 3. [Crohn's disease, primary sclerosing cholangitis and antiphospholipid syndrome: an uncommon association].
    Romdhane H, Karoui S, Serghini M, Boubaker J, Filali A.
    Tunis Med; 2009 May; 87(5):349-51. PubMed ID: 19927768
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW.
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Crohn's disease and amyloidosis. An association to be considered].
    Sánchez Lombraña JL, Triviño A, Linares A, Navascués CA, Pérez R, Rodríguez M, Rodrigo L.
    Rev Esp Enferm Dig; 1991 Nov; 80(5):337-41. PubMed ID: 1768475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report.
    Demarchi B, Bresso F, Novero D, Palestro G, Sapone N, Pellicano R, Bonardi R, Smedile A, Rizzetto M, Astegiano M.
    Minerva Gastroenterol Dietol; 2007 Sep; 53(3):279-83. PubMed ID: 17912190
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum angiotensin-converting-enzyme in Crohn's disease.
    Nunez-Gornes JF, Tewksbury DA.
    Am J Gastroenterol; 1981 May; 75(5):384-5. PubMed ID: 6267935
    [Abstract] [Full Text] [Related]

  • 15. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
    Rönnblom A, Holmström T, Tanghöj H, Rorsman F, Sjöberg D.
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1288-92. PubMed ID: 25777994
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum lysozyme in Crohn's disease. A useful index of disease activity.
    Falchuk KR, Perrotto JL, Isselbacher KJ.
    Gastroenterology; 1975 Oct; 69(4):893-6. PubMed ID: 1175883
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.